The National Institute of Dental and Craniofacial Research (NIDCR) awarded a Project Grant (CFDA 93.121 - Oral Diseases and Disorders Research) to the University of Arizona in the amount of $118,763 for the period of September 1, 2024 to August 31, 2026. The grant will support Dr. Robert Jackson's research focused on assessing the role of human papillomavirus type 16 (HPV16) in transforming versus productive infections in oral epithelial tissues. The research aims to characterize the viral...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $2,803,617.00 in funding to Emory University to study the intersection of HIV-related periodontitis and antiretroviral therapy-induced immune reconstitution bone loss in people living with HIV. The research aims to investigate how these two conditions, which can both lead to alveolar bone and tooth loss, impact oral...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $608,632.33 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to The Research Foundation For The State University Of New York (RF SUNY). The award, effective September 1, 2024, supports a research project investigating the role of rare chemosensory epithelial cells known as "tuft cells" in salivary gland immunity. The project aims to utilize advanced microscopic techniques,...
This federal Project Grant award, with ID R01DE035025, was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121). The $583,289 grant will fund a 5-year research project at the University of Arkansas for Medical Sciences (UAMS) to study the epigenetic regulation of Kaposi's sarcoma-associated herpesvirus (KSHV) latency. The research aims to advance the understanding of how KSHV, which causes several...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $226,500 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to The Medical University of South Carolina. The grant, titled "CD38 Signaling in Aging-Associated Immune Responses Induced by Oral Pathogens," aims to define how oral pathogens affect aging-associated immune responses and determine if inhibition of the CD38 enzyme can alleviate inflammatory bone loss and...
This Project Grant award of $2,740,126 from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will fund research to understand the factors contributing to increased oropharyngeal cancer (OPC) among people living with HIV (PWH). The University of Alabama at Birmingham will conduct this 5-year research project to investigate how chronic HIV infection and inflammation impact HPV infection, gene expression, and T...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a Project Grant (CFDA 93.121 - Oral Diseases and Disorders Research) in the amount of $473,632 to the University of Toledo on May 1, 2025. The purpose of this 3-year project is to investigate the role of megakaryocytes (MEGs) and their response to the cytokine interleukin-17 (IL-17) in oral mucosal immunity, particularly during oropharyngeal candidiasis caused by Candida albicans. The research aims to elucidate the...
This Project Grant award of $155,500 from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will support a comprehensive examination of the oral virome and its interactions with the oral microbiome. The research aims to shed light on the role of viruses in maintaining oral health and contributing to disease, with the goal of illuminating a neglected aspect of the oral microenvironment and potentially...
The federal Project Grant award of $1,403,398 was granted on September 2, 2024 by the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research Federal Grant Program (CFDA 93.121). The award supports research aimed at utilizing advanced imaging approaches to develop imaging-based biomarkers related to the hybrid epithelial/mesenchymal state (HEM) and its interactions with the immune system in head and neck squamous cell carcinoma (HNSCC)....
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $600,029 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to Cedars-Sinai Medical Center. The grant, which runs from March 10, 2025 to February 28, 2030, supports research to elucidate the molecular and cellular mechanisms by which Ras/MAPK signaling dysregulation causes abnormal enamel formation and craniofacial development. The research aims to determine how Ras signaling disruption...